Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  liposome-incorporated Grb2 antisense oligodeoxynucleotide
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
Clinical Trial of BP1001 (L-Grb-2 Antisense Oligonucleotide) in CML, AML, ALL & MDS
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 to 70
Trial IDs: 2003-0578 (v) 08-8, NCI-2010-01675, 2003-0578 (v) 08-4, NCT01159028
Start Over